The Italy Microsampling Devices Market was valued at $1.21 Million in 2024 and projected to reach to $1.66 Million by 2029, representing a compound annual growth rate of 6.5%. Italy's microsampling devices market is positioned for steady growth driven by increasing healthcare expenditure and the adoption of minimally invasive diagnostic procedures.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Italy's microsampling devices market is valued at $1.21 million in 2024, with strong growth trajectory projected to reach $1.66 million by 2029, demonstrating robust market expansion.
The Italian market is growing at a CAGR of 6.5%, slightly below the global average of 7.6%, indicating steady but measured adoption of microsampling technologies in Italian healthcare settings.
Italy's advanced healthcare infrastructure is progressively integrating minimally invasive diagnostic technologies, with microsampling devices gaining traction across hospitals, diagnostic centers, and clinical laboratories.
Italy's alignment with EU medical device regulations and CE marking requirements creates a standardized framework supporting the adoption and commercialization of microsampling devices across the country.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | LANCETS (Product) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 7.6% from 2024 to 2029 |
| Largest Segment | SINGLE-USE BLOOD COLLECTION DEVICES (Usability) |
| Market Size Base Year (Billions) | ~USD 0.09 (2024) |
| Revenue Forecast (Billions) | ~USD 0.14 (2029) |
| Segments Covered | Product, Sample Type, Collection Method, Device Type, Usability, Application |
6 segment dimensions are covered across the global market.
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CLINICAL TRIALS & RESEARCH | 0.52 | 0.52 | 0.53 | 0.54 | 0.55 | 0.57 | 0.6 | 0.64 | 4 |
| DISEASE DIAGNOSTICS | 0.68 | 0.7 | 0.71 | 0.73 | 0.76 | 0.8 | 0.85 | 0.91 | 5.1 |
| HEALTH SCREENING & PREVENTIVE HEALTH | 1.16 | 1.2 | 1.24 | 1.29 | 1.36 | 1.45 | 1.56 | 1.7 | 6.5 |
| OTHER APPLICATIONS | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.16 | 0.17 | 0.18 | 3.4 |
| TOTAL | 2.52 | 2.57 | 2.63 | 2.71 | 2.83 | 2.98 | 3.18 | 3.43 | 5.5 |
Italy's microsampling devices market was valued at $1.21 million in 2024 and is expected to grow to $1.66 million by 2029.
Italy's microsampling devices market is projected to grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2029.
Key drivers in Italy include an aging population, increased demand for minimally invasive diagnostics, supportive regulatory policies, and growing adoption of point-of-care testing solutions.
Italy's 6.5% CAGR reflects steady market development within Europe, with Italy benefiting from healthcare infrastructure improvements and increased clinical validation of microsampling technologies.
Italy's market is primarily driven by point-of-care testing, home-based diagnostics, and clinical laboratory applications that benefit from reduced sample volumes and improved patient comfort.
The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. To track company developments such as acquisitions, product launches, expansions, agreements, and partnerships of the leading players, the competitive landscape of the at-home blood collection devices market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.
The four steps involved in estimating the market size are
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.
The following is a breakdown of the primary respondents:

Note 1: Others include sales managers, marketing managers, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2023, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
|
COMPANY NAME |
DESIGNATION |
|
YourBio Health |
Sales Executive |
|
Capitainer |
Sales Executive |
Both top-down and bottom-up approaches were used to estimate and validate the at-home blood collection devices market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

To know about the assumptions considered for the study, Request for Free Sample Report
After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
At-home blood collection devices are tools designed to allow individuals or professionals to collect small blood samples from home care settings. These devices are easy to use and minimally invasive, making them suitable for various applications.
MarketsandMarkets offers the following customizations for this market report.
Full forecast, segment splits, and company analysis for all Microsampling Devices Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report